Doctors Note Logo

Published on: 9/15/2026

Is 50 mg of trazodone too low a dose to actually make me sleep?

For insomnia, 50 mg is a common and often effective dose, since trazodone's sedating effect works at low doses (usually 25 to 100 mg) rather than the much higher doses used for depression. If it is not helping you fall or stay asleep, the reason may be timing of the dose, tolerance, caffeine or alcohol, other medications, or an underlying issue such as sleep apnea, anxiety, pain, or restless legs, and simply raising the dose can increase next-day grogginess, dizziness, and other risks without better sleep. There are several important factors to weigh before assuming the dose is too low, including when your symptoms started and what else is affecting your sleep, so see below to understand more.

Because ongoing sleep trouble on a sedating medication can point to something treatable that a dose change will not fix, it helps to organize your symptoms before your next appointment: take a free, instant, online symptom check to see what may be driving your insomnia. It takes only a few minutes, is private, and gives you clear, personalized guidance on possible causes and the right next steps to discuss with a clinician.

Last reviewed for medical accuracy: 09/15/2026

answer background

Explanation

Is 50 mg of trazodone too low a dose to actually make me sleep?

Trazodone is a medication commonly prescribed off-label for insomnia. If you’ve been told to take 50 mg at bedtime but aren’t sure if that’s enough to help you sleep, you’re not alone. Below, we’ll review how trazodone works, typical dosing, factors that affect its effectiveness, and safe ways to boost sleep quality. We’ll stay grounded in credible, up-to-date sources so you can make informed choices—and know when to talk to your doctor.


What is trazodone and how does it help with sleep?

  • Trazodone is an antidepressant in the class of serotonin-modulating agents.
  • Its sleep‐promoting effect comes from blocking certain serotonin receptors (5-HT2A) and histamine (H1) receptors, which produces sedation.
  • Although FDA-approved for depression, low-dose trazodone (25–100 mg) is widely used off-label to treat insomnia.
  • Compared to traditional sleep aids (like benzodiazepines or “Z-drugs”), trazodone generally has lower risk of tolerance or dependence.

Key point: Trazodone isn’t a classic sleep medication, but at low doses it often helps people fall and stay asleep without the “hangover” of some hypnotics.


Standard dosing guidelines for insomnia

Prescription info from credible sources (including the FDA label and clinical practice references) generally suggests:

  • Starting dose: 25–50 mg, taken 30–60 minutes before bedtime
  • Usual dose range for sleep: 50–150 mg nightly
  • Maximum dose (for depression): up to 400 mg/day, but that’s well above what’s used for insomnia

In many sleep studies, doses of 50 mg to 100 mg showed improvements in total sleep time and sleep quality compared to placebo. If you’re taking only 50 mg, you’re at the low end of the therapeutic range—but not necessarily “too low.”


Will 50 mg of trazodone work for you?

Several factors determine whether 50 mg is enough:

  1. Individual sensitivity

    • Some people respond well to 25–50 mg, reporting good sleep without morning grogginess.
    • Others may need higher doses to feel a meaningful sedative effect.
  2. Concurrent medications

    • Drugs that speed up trazodone metabolism (certain anticonvulsants) may reduce its effectiveness.
    • Medications that inhibit liver enzymes (some antidepressants, antifungals) can increase trazodone levels—potentially boosting sleep effects or side effects.
  3. Tolerance

    • Long-term use can lead to partial tolerance. If you’ve taken trazodone nightly for months, 50 mg might not feel as strong as when you first started.
  4. Underlying sleep issues

    • Chronic insomnia, restless legs syndrome, sleep apnea or other conditions may require a different approach (behavioral therapy, addressing medical causes) rather than simply upping the dose.

Bottom line: 50 mg may be enough for many people, especially at treatment start. If you’re still tossing and turning after a week or two, discuss adjusting your dose or exploring additional therapies.


Potential benefits of starting at 50 mg

  • Lower side-effect risk. Dizziness, orthostatic hypotension (feeling lightheaded when standing), and dry mouth tend to increase with higher doses.
  • Minimal next-day drowsiness. While some people do experience morning grogginess at any dose, many tolerate 50 mg without major carry-over sedation.
  • Reduced risk of interactions. At lower doses, trazodone is less likely to interact with other sedatives or substances that depress the central nervous system.

If you tolerate 50 mg well but still feel awake, your doctor may suggest slowly increasing to 75 mg or 100 mg. That step-up is common and typically done in 25–50 mg increments.


Safety considerations and common side effects

Even at 50 mg, trazodone can cause side effects. Knowing what to watch for helps you and your provider find the sweet spot between sleep benefit and risk.

Common side effects (mild to moderate):

  • Dizziness or lightheadedness, especially when standing
  • Headache
  • Nausea or upset stomach
  • Dry mouth
  • Blurred vision

Less common but important (seek help if you notice):

  • Unexplained chest pain or rapid heartbeat
  • Severe muscle stiffness or tremors
  • Priapism (a painful, prolonged erection)—rare but a medical emergency
  • Signs of serotonin syndrome (fever, agitation, rapid heart rate)—especially if combined with other serotonergic drugs

Always report serious or unusual symptoms to your healthcare provider right away. For non-urgent questions about side effects, a free, online symptom check, using the doctor approved Ubie Symptom Checker can help you decide whether to seek care.


Tips to maximize trazodone’s sleep-promoting effect

Medication is one tool; combining it with good sleep habits can boost results. Try these strategies:

  • Maintain a consistent bedtime and wake-up time, even on weekends.
  • Create a relaxing pre-sleep routine (reading, light stretching, meditation).
  • Keep your bedroom dark, cool and quiet—consider blackout curtains or white-noise.
  • Limit caffeine after mid-afternoon.
  • Avoid heavy meals or alcohol close to bedtime.
  • Turn off screens (phones, tablets, TVs) at least 30–60 minutes before sleep.

By improving sleep hygiene, you may find that a lower dose of trazodone becomes more effective.


When to talk to your doctor

Increasing your trazodone dose on your own is not recommended. Always discuss changes with a healthcare professional. Reach out if you:

  • Still can’t fall asleep 30–60 minutes after taking 50 mg for 1–2 weeks
  • Develop troublesome side effects (dizziness, priapism, mood changes)
  • Experience daytime fatigue or impairment
  • Have new or worsening medical issues (chest pain, severe headache, breathing difficulty)

For non-urgent questions or to check how concerning your symptoms are, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker before scheduling your visit.


Key takeaways

  • 50 mg of trazodone is a common starting dose for insomnia and may work well for many people.
  • The usual sleep-target range is 50–150 mg, adjusted based on response and tolerability.
  • Side effects are generally mild at lower doses, but serious reactions can occur—talk to your doctor if you notice anything unusual.
  • Pair trazodone with good sleep hygiene to get the most benefit.
  • Never adjust your dose without professional guidance.

If you’re unsure whether 50 mg is right for you, or if your sleep remains poor, talk to your doctor. For non-urgent symptom guidance, you can try a free, online symptom check, using the doctor approved Ubie Symptom Checker. And remember: always speak to a healthcare professional about any life-threatening or serious concerns.

(References)

  • * Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of Antidepressants on Sleep. Curr Psychiatry Rep. 2017 Aug 9;19(9):63. doi: 10.1007/s11920-017-0816-4. Epub 2017 Aug 9. PMID: 28791566; PMCID: PMC5548844.

  • * Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018 Apr;70(2):197-245. doi: 10.1124/pr.117.014381. PMID: 29487083.

  • * Jaffer KY, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, Abdelmesseh M, Danovitch I, Ishak WW. Trazodone for Insomnia: A Systematic Review. Innov Clin Neurosci. 2017 Jul-Aug;14(7-8):24-34. Epub 2017 Aug 1. PMID: 29552421; PMCID: PMC5842888.

  • * Trazodone. 2006. PMID: 30000237.

  • * Abad VC, Guilleminault C. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018 Sep;35(9):791-817. doi: 10.1007/s40266-018-0569-8. PMID: 30058034.

  • * Bruni O, Angriman M, Melegari MG, Ferri R. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother. 2019 Dec;20(18):2257-2271. doi: 10.1080/14656566.2019.1674283. Epub 2019 Oct 22. PMID: 31638842.

  • * Ek J, Jacobs W, Kaylor B, McCall WV. Addiction and Sleep Disorders. Adv Exp Med Biol. 2021;1297:163-171. doi: 10.1007/978-3-030-61663-2_12. PMID: 33537944.

  • * Wichniak A, Wierzbicka AE, Jarema M. Treatment of insomnia - effect of trazodone and hypnotics on sleep. Psychiatr Pol. 2021 Aug 31;55(4):743-755. doi: 10.12740/PP/125650. Epub 2021 Aug 31. PMID: 34994734.

  • * De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, Kurtulmus A, Tomlinson A, Mitrova Z, Foti F, Del Giovane C, Quested DJ, Cowen PJ, Barbui C, Amato L, Efthimiou O, Cipriani A. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170-184. doi: 10.1016/S0140-6736(22)00878-9. PMID: 35843245.

  • * Kokkali M, Pinioti E, Lappas AS, Christodoulou N, Samara MT. Effects of Trazodone on Sleep: A Systematic Review and Meta-analysis. CNS Drugs. 2024 Oct;38(10):753-769. doi: 10.1007/s40263-024-01110-2. Epub 2024 Aug 9. PMID: 39123094.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.